Advertisement

Alkylating agents

  • Thomas A. Connors
Conference paper
Part of the Topics in Current Chemistry Fortschritte der Chemischen Forschung book series (TOPCURRCHEM, volume 52)

Keywords

Alkylating Agent Platinum Complex Platinum Compound Sulphur Mustard Nitrogen Mustard 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1).
    Meyer, V.: Ber. dtsch. chem. Ges. 1, 1725 (1887).CrossRefGoogle Scholar
  2. 2).
    Ehrlich, P.: Collected Papers of Paul Ehrlich I (ed. F. Himmelweit), pp. 596–618. London: Pergamon Press 1956.Google Scholar
  3. 3).
    Krumbhaar, E. B., Krumbhaar, H. D.: J. Med. Res. 40, 497 (1919).Google Scholar
  4. 4).
    Berenblum, L: J. Path. Bact. 40, 549 (1935).CrossRefGoogle Scholar
  5. 5).
    Adair, F. E., Bagg, H. J.: Ann. Surg. 93, 190 (1931).CrossRefGoogle Scholar
  6. 6).
    Gilman, A.: Am. J. Surgery 105, 574 (1963).CrossRefGoogle Scholar
  7. 7).
    Gilman, A., Philips, F. S.: Science 103, 409 (1946).CrossRefGoogle Scholar
  8. 8).
    Peck, R. M., O'Connell, A. P., Creech, H. J.: J. Med. Chem. 9, 217 (1966).CrossRefGoogle Scholar
  9. 9).
    Hebborn, P., Triggle, D. J.: J. Med. Chem. 8, 541 (1965).CrossRefGoogle Scholar
  10. 10).
    Reist, E. J., Spencer, R. R., Wain, M. E., Junga, I. G., Goodman, L., Baker, B. R.: J. Org. Chem. 26, 2821 (1961).CrossRefGoogle Scholar
  11. 11).
    Sellei, C., Eckhardt, S., Nemeth, L.: Chemotherapy of neoplastic diseases. Budapest: Akademiai Kiado 1970.Google Scholar
  12. 12).
    Elson, L. A., Jarman, M., Ross, W. C. J.: Europ. J. Cancer 4, 617 (1968).Google Scholar
  13. 13).
    Connors, T. A., Jeney, A., Jones, M.: Biochem. Pharmacol. 13, 1545 (1964).CrossRefGoogle Scholar
  14. 14).
    Ross, W. C. J.: Adv. Cancer Res. 1, 397 (1953).CrossRefGoogle Scholar
  15. 15).
    Ross, W. C. J.: Biological alkylating agents. London: Butterworths 1962.Google Scholar
  16. 16).
    Price, C. C., Gaucher, G. M., Koneru, P., Shibakawa, R., Sowa, J. R., Yamaguchi, M.: Ann. N. Y. Acad. Sci. 163, 593 (1969).CrossRefGoogle Scholar
  17. 17).
    Bardos, T. J., Chmielewicz, Z. F., Hebborn, P.: Ann. N. Y. Acad. Sci. 163, 1006 (1969).CrossRefGoogle Scholar
  18. 18).
    Williamson, C. E., Witten, B.: Cancer Res. 27, 23 (1967).Google Scholar
  19. 19).
    Stock, J. A. in: Drug design (ed. E. J. Ariens): vol. 2, pp. 531–571. New York and London: Academic Press 1971.Google Scholar
  20. 20).
    Wheeler, G. P.: Cancer Res. 22, 651 (1962).Google Scholar
  21. 21).
    Ochoa, M., Hirschberg, E.: Alkylating agents in experimental chemotherapy. (eds. R. J. Schnitzer and F. Hawking), pp. 1–32. London and New York: Academic Press 1967.Google Scholar
  22. 22).
    Elson, L. A.: Radiation and radiomimetic chemicals. Comparative physiological effects. London: Butterworths 1963.Google Scholar
  23. 23).
    Skipper, H. E.: The cell cycle and the chemotherapy of cancer, in: The cell cycle and cancer (ed. R. Baserga), pp. 355–387). New York: Marcel Dekker 1971.Google Scholar
  24. 24).
    Papirmeister, B., Davison, C. L.: Biochem. Biophys. Acta 103, 70 (1965).Google Scholar
  25. 25).
    Rueckert, R. R., Mueller, G. C.: Cancer Res. 20, 1584 (1960).Google Scholar
  26. 26).
    Jae Ho Kim, Eidinoff, M. L.: Cancer Res. 25, 698 (1965).Google Scholar
  27. 27).
    Cohen, S. S., Barner, H. D.: Paediatrics 16, 704 (1955).Google Scholar
  28. 28).
    Van Putten, L. M., Lelieveld, P.: Europ. J. Cancer 7, 11 (1971).Google Scholar
  29. 29).
    The Cell Cycle and Cancer (ed. R. Baserga). New York: Marcel Dekker 1971.Google Scholar
  30. 30).
    Skipper, H. E.: Cancer Res. 29, 2329 (1969).Google Scholar
  31. 31).
    Brooks, P., Lawley, P. D.: Brit. med. Bull. 20, 91 (1964).Google Scholar
  32. 32).
    Brooks, P. in: Chemotherapy of cancer (ed. P. A. Plattner), p. 32. Amsterdam: Elsevier 1964.Google Scholar
  33. 33).
    Golder, R. M., Martin-Guzman, G., Jones, J., Goldstein, N. O., Rotenberg, S., Rutman, R. J.: Cancer Res. 24, 964 (1964).Google Scholar
  34. 34).
    Linford, J. H., Froese, A., Israels, L. G.: Nature 197, 1068 (1963).CrossRefGoogle Scholar
  35. 35).
    Riches, P. G., Harrap, K. R.: Cancer Res. 33, 389 (1973).Google Scholar
  36. 36).
    Wheeler, G. P.: Cancer Res. 23, 1334 (1963).Google Scholar
  37. 37).
    Bratzel, R. P.: Cancer Chemother. Rep. 26, 1 (1963).Google Scholar
  38. 38).
    Schmidt, L. M., Fradkin, R., Sullivan, R., Flowers, A.: Cancer Chemother. Rep., Suppl. 2, Parts I, II and III. National Institutes of Health, Bethesda, Maryland: 1965.Google Scholar
  39. 39).
    Boesen, E., Davis, W.: Cytotoxic drugs in the treatment of cancer. London: Arnold 1969.Google Scholar
  40. 40).
    Brule, G., Eckhardt, S. J., Hall, T. C., Winkler, A.: Drug therapy of cancer. Geneva: World Health Organisation 1973.Google Scholar
  41. 41).
    Ansfield, F. J.: Chemotherapy of malignant neoplasms. Springfield, Illinois: C. C. Thomas 1973.Google Scholar
  42. 42).
    Whisson, M. E., Connors, T. A.: Nature 206, 689 (1965).CrossRefGoogle Scholar
  43. 43).
    Clifford, P. in: Burkitt's lymphoma (eds. D. P. Burkitt and D. H. Wright), p. 52. Edinburgh and London: E. and S. Livingstone 1970.Google Scholar
  44. 44).
    Roberts, J. J. in: DNA repair mechanisms, p. 41. Stuttgart and New York: F. C. Schattauer Verlag 1972.Google Scholar
  45. 45).
    Adamson, R. H.: Ann. N. Y. Acad. Sci. 179, 432 (1971).CrossRefGoogle Scholar
  46. 46).
    Calvert, N., Connors, T. A., Ross, W. C. J.: Europ. J. Cancer 4, 627 (1968).Google Scholar
  47. 47).
    Weber, G. in: Liver cancer. 1. A. C. R. Scientific Publication No. 1, p. 69. Lyon: 1971.Google Scholar
  48. 48).
    Ross, W. C. J.: Biochem. Pharm. 8, 235 (1961).CrossRefGoogle Scholar
  49. 49).
    Connors, T. A., Mitchley, B. C. V., Rosenoer, V. M., Ross, W. C. J.: Biochem. Pharm. 13, 395 (1964).CrossRefGoogle Scholar
  50. 50).
    Davis, W., Ross, W. C. J.: J. Med. Chem. 8, 757 (1965).CrossRefGoogle Scholar
  51. 51).
    Meyza, J., Cobb, L. M.: Cancer 27, 369 (1971).CrossRefGoogle Scholar
  52. 52).
    Bukhari, A., Connors, T. A., Gilsenan, A. M., Ross, W. C. J., Tisdale, M. J., Warwick, G. P., Wilman, D. E. V.: J. Natl. Cancer Inst. 50, 243 (1973).Google Scholar
  53. 53).
    Connors, T. A., Whisson, M. E.: Nature 210, 866 (1966).CrossRefGoogle Scholar
  54. 54).
    Connors, T. A., Farmer, P. B., Foster, A. B., Gilsenan, A. M., Jarman, M., Tisdale, M. J.: Biochem. Pharm. In press 1973.Google Scholar
  55. 55).
    Young, C.: Personal communication.Google Scholar
  56. 56).
    Trams, E. G., Nadkarni, M. V.: Cancer Res. 16, 1069 (1956).Google Scholar
  57. 57).
    Connors, T. A.: Biochem. Pharmacol. In press 1974.Google Scholar
  58. 58).
    Connors, T. A., Cox, P. J., Farmer, P. B., Foster, A. B., Jarman, M.: Biochem. Pharm. In press 1973.Google Scholar
  59. 59).
    Brock, N., Arnold, M., Bourseaux, F.: Angew. Chem. 70, 539 (1958).CrossRefGoogle Scholar
  60. 60).
    Foley, G. E., Friedman, O. M., Drolet, B. P.: Cancer Res. 21, 57 (1961).Google Scholar
  61. 61).
    Brock, N.: Cancer Chemother. Rep. 51, 315 (1967).Google Scholar
  62. 62).
    Struck, R. F., Kirk, M. C., Mellett, L. B., El Dareer, S., Hill, D. L.: Mol. Pharmacol. 7, 519 (1971).Google Scholar
  63. 63).
    Hill, D. L., Kirk, M. C., Struck, R. F.: J. Amer. Chem. Soc. 92, 3207 (1970).CrossRefGoogle Scholar
  64. 64).
    Alarcon, R. A., Meienhofer, J.: Nature, New Biology 233, 250 (1971).Google Scholar
  65. 65).
    Colvin, M., Padgett, C. A., Fenselau, C.: Cancer Res. 33, 915 (1973).Google Scholar
  66. 66).
    Phillips, B. J.: Biochem. Pharm. In press 1973.Google Scholar
  67. 67).
    Takamizawa, A., Matsumoto, S., Iwata, T., Katagiri, K., Tochino, Y., Yamaguchi, K.: J. Amer. Chem. Soc. 95, 985 (1973).CrossRefGoogle Scholar
  68. 68).
    Ball, C. R., Connors, T. A.: Biochem. Pharm. 16, 509 (1967).CrossRefGoogle Scholar
  69. 69).
    Goldenthal, E. I., Nadkarni, M. V., Smith, P. K.: Radial. Res. 10, 571 (1959).CrossRefGoogle Scholar
  70. 70).
    Calcutt, G., Connors, T. A.: Biochem. Parm. 12, 839 (1963).CrossRefGoogle Scholar
  71. 71).
    Ball, C. R.: Rec. Res. Cancer Res. 21, 26 (1969).Google Scholar
  72. 72).
    Ball, C. R., Connors, T. A., Double, J. A., Ujhazy, V., Whisson, M. E.: Int. J. Cancer 1, 319 (1966).CrossRefGoogle Scholar
  73. 73).
    Roberts, J. J., Crathorn, A. R., Brent, T. P.: Nature 218, 970 (1968).CrossRefGoogle Scholar
  74. 74).
    Gaudin, D., Yielding, K. L.: Proc. Soc. exp. Biol. Med. 131, 1413 (1969).Google Scholar
  75. 75).
    Clarke, D. A., Barclay, R. K., Stock, C. C., Rondestedt, C. S.: Proc. Soc. exp. Biol. Med. 90, 484 (1955).Google Scholar
  76. 76).
    Carter, S. K., Friedman, M. A.: Europ. J. Cancer 8, 85 (1972).Google Scholar
  77. 77).
    Audette, R. C. S., Connors, T. A., Mandel, H. G., Merai, K., Ross, W. C. J.: Biochem. Pharm. 22, 1855 (1973).CrossRefGoogle Scholar
  78. 78).
    Preussman, R., Druckrey, H., Ivankovic, S., Hodenberg, A.: Ann. N. Y. Acad. Sci. 163, 697 (1969).CrossRefGoogle Scholar
  79. 79).
    Carter, S. K., Schabel, F. M., Broder, L. E., Johnston, T. P.: Adv. Cancer Res. 16, 273 (1972).Google Scholar
  80. 80).
    D'Angelo, J. M., Groth, D. P., Vogler, W. R.: Proc. Int. Cancer Congr. 10th, 1970. Oncology, 1970, Abst. p 408. (Eds Clark, Cumley, McCay and Copeland). Houston: Year Book Medical Publishers.Google Scholar
  81. 81).
    Green, S., Bodansky, O.: Proc. Amer. Assoc. Cancer Res. 8, 23 (1967).Google Scholar
  82. 82).
    Wheeler, G. P., Bowdon, B. J.: Cancer Res. 28, 52 (1968).Google Scholar
  83. 83).
    Rosenberg, B., van Camp, L., Krigas, T.: Nature 205, 698 (1965).CrossRefGoogle Scholar
  84. 84).
    Rosenberg, B., van Camp, L., Grimley, E., Thomson, A. J.: J. Biol. Chem. 242, 1347 (1967).Google Scholar
  85. 85).
    Rosenberg, B., van Camp, L., Trosko, J. E., Mansour, V. H.: Nature 222, 385 (1969).CrossRefGoogle Scholar
  86. 86).
    Cleare, M. J., Hoeschele, J. D.: Platinum Metals Review 17, 2 (1973).Google Scholar
  87. 87).
    Connors, T. A., Jones, M., Ross, W. C. J., Braddock, P. D., Khokhar, A. R., Tobe, M. L.: Chem. Biol. Interactions 5, 415 (1972).CrossRefGoogle Scholar
  88. 88).
    Howle, J. A., Gale, G. R.: Biochem. Pharm. 19, 2757 (1970).CrossRefGoogle Scholar
  89. 89).
    Roberts, J. J., Pascoe, J. M.: Nature 235, 282 (1972).CrossRefGoogle Scholar
  90. 90).
    Thomson, A.: Roe. Res. Cancer Res. In press.Google Scholar
  91. 91).
    Connors, T. A.: Proc. VIIth International Congress of Chemotherapy. In: Adv. Antimicrobial and Antineoplastic Chemotherapy 2, 237 (1972).Google Scholar
  92. 92).
    Wiltshaw, E.: Rec. Res. Cancer Res. In press.Google Scholar
  93. 93).
    Culvenor, C. C. J., Downing, D. T., Edgar, J. A.: Ann. N. Y. Acad. Sci. 163, 837 (1969).CrossRefGoogle Scholar
  94. 94).
    Baker, B. R.: Design of active-site-directed irreversible enzyme inhibitors. New York: J. Wiley & Sons 1967.Google Scholar
  95. 95).
    Stock, J. A.: Chemotherapy of neoplastic diseases. In: Experimental chemotherapy (eds. R. J. Schnitzer and F. Hawking), vol. 5, Part II, p. 333. New York: Academic Press 1967.Google Scholar
  96. 96).
    Miller, E. C., Miller, J. A.: Ann. N. Y. Acad. Sci. 163, 731 (1969).CrossRefGoogle Scholar
  97. 97).
    Schoental, R.: Ann. Rev. Pharmacol. 7, 343 (1967).CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1947

Authors and Affiliations

  • Thomas A. Connors
    • 1
  1. 1.Chester Beatty Research Institute, Institute of Cancer ResearchRoyal Cancer HospitalLondonEngland

Personalised recommendations